Abstract
The metabolic syndrome (MS) has a high prevalence in different countries (∼ 10% in France). It associates in the same subject central obesity, decrease in HDL cholesterol, increase in plasma triglycérides, glucose intolerance and hypertension. Insulin-resistance is a common feature even though it has been excluded from the more recent definitions because of the difficulty to assess it in clinical practice. Physiopathology of MS is not univocal. Stress, insulin resistance, central obesity are concerned. Marine omega 3 fatty acids (EPA and DHA) have demonstrated in many studies in rodents and some studies in humans their potentiality to prevent and treat MS, by their insulin-sensitizing effect, their ability to modulate mental stress response, to decrease plasma triglycerides, to reduce lipotoxicity, to slow down atherogenesis, to decrease oxidative stress and to ameliorate endothelial dysfunction. Additional studies are required to definitively confirm their usefulness and define their optimal daily amount for prevention and treatment beside physical activity, maintenance or reduction of body weight and pharmacological therapy of specific components of MS.
Keywords: Insulin resistance, non esterified fatty acids, Hypertriglyceridaemia, visceral adipose tissue, VLDL Production
Current Nutrition & Food Science
Title: Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?
Volume: 3 Issue: 2
Author(s): J. Delarue, V. Le Guen, G. Allain, C. Corporeau and S. Guillerm
Affiliation:
Keywords: Insulin resistance, non esterified fatty acids, Hypertriglyceridaemia, visceral adipose tissue, VLDL Production
Abstract: The metabolic syndrome (MS) has a high prevalence in different countries (∼ 10% in France). It associates in the same subject central obesity, decrease in HDL cholesterol, increase in plasma triglycérides, glucose intolerance and hypertension. Insulin-resistance is a common feature even though it has been excluded from the more recent definitions because of the difficulty to assess it in clinical practice. Physiopathology of MS is not univocal. Stress, insulin resistance, central obesity are concerned. Marine omega 3 fatty acids (EPA and DHA) have demonstrated in many studies in rodents and some studies in humans their potentiality to prevent and treat MS, by their insulin-sensitizing effect, their ability to modulate mental stress response, to decrease plasma triglycerides, to reduce lipotoxicity, to slow down atherogenesis, to decrease oxidative stress and to ameliorate endothelial dysfunction. Additional studies are required to definitively confirm their usefulness and define their optimal daily amount for prevention and treatment beside physical activity, maintenance or reduction of body weight and pharmacological therapy of specific components of MS.
Export Options
About this article
Cite this article as:
Delarue J., Le Guen V., Allain G., Corporeau C. and Guillerm S., Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?, Current Nutrition & Food Science 2007; 3 (2) . https://dx.doi.org/10.2174/157340107780598663
DOI https://dx.doi.org/10.2174/157340107780598663 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biosynthesis and Biological Activities of In Vitro Derived Solasodine Glycoalkaloids from <i>Solanum laciniatum</i>
The Natural Products Journal Nitroimidazole Radiopharmaceuticals in Bioimaging: Part I: Synthesis and Imaging Applications
Current Radiopharmaceuticals A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Advances in the Chemistry of Saccharins: From Synthetic Novelties Towards Biologically Active Compounds
Current Medicinal Chemistry The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Current Medicinal Chemistry Serum Uric Acid and Risk of Coronary Heart Disease
Current Pharmaceutical Design Anti-HIV Drug Development: Structural Features and Limitations of Present Day Drugs and Future Challenges in the Successful HIV/AIDS Treatment
Current Pharmaceutical Design Editorial (Hot Topic:Recent Advance in the Studies of Beta-glucans for Cancer Therapy)
Anti-Cancer Agents in Medicinal Chemistry Inhibition of sPLA2-IIA, C-reactive Protein or Complement: New Therapy for Patients with Acute Myocardial Infarction?
Cardiovascular & Hematological Disorders-Drug Targets Antioxidant Activity of Resveratrol Analogs
Letters in Drug Design & Discovery Nebivolol: More Than a Highly Selective Beta Blocker
Recent Patents on Cardiovascular Drug Discovery Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design Recent Developments in the Field of Quinazoline Chemistry
Current Organic Chemistry Endogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Current Vascular Pharmacology From Early Origins. When and Why does Asthma Develop?
Current Pediatric Reviews Target Oxygen Levels and Critical Care of the Newborn
Current Pediatric Reviews A Micro-Aggregation Algorithm Based on Density Partition Method for Anonymizing Biomedical Data
Current Bioinformatics Omega-3 Fatty Acids in the Management of Epilepsy
Current Topics in Medicinal Chemistry